Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Palo Santo
Chicago, Illinois, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Palo Santo manages and invests in a portfolio of more than 28 companies developing innovative psychedelic-based medicines and technologies for mental health and addiction, with its aim to increase their clinical development, FDA approval, patient access, and affordability
- Therapeutic areas
- Psychiatry
- Industry
- Investors
02
Partnerships
Atai Life SciencesBeckley PsytechCharles D. NicholsJohn D. McCorvyJulie HollandJohn F. GredenStephen Wright
Beyond the preview
Go deeper on Palo Santo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Palo Santo.